| Dr Danielle Saint Ulme Jean, MD | |
|
3301 Wilson Blvd, Arlington, VA 22201 | |
| (703) 243-6720 | |
| Not Available |
| Full Name | Dr Danielle Saint Ulme Jean |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 19 Years |
| Location | 3301 Wilson Blvd, Arlington, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194923193 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kaiser Foundation Health Plan Of The Mid-atlantic States,inc | 3779495858 | 1673 |
News Archive
Today, the success of the Young Investigator Grant for Probiotics Research (YIGPRO) program was confirmed with the announcement of two $50,000 grants that are available to rising young investigators in the field of probiotics. 2010 marks the third consecutive year for the grants. The grants were established by The Global Probiotics Council (GPC), a committee formed by DANONE and Yakult Honsha Co., Ltd., and are designed to contribute to the advancement of probiotics and gastrointestinal microbiota research in the United States.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), announced today that it has entered into a research collaboration with Mirna Therapeutics (Austin, TX), to determine the utility of combining RXi's proprietary rxRNA™ technology with Mirna's microRNA mimics as potential therapeutics in oncology. The parties will each contribute technology and resources to the collaboration to generate and evaluate novel microRNA compounds.
Millions of people worldwide suffer from a type of chronic pain called neuropathic pain, which is triggered by nerve damage. Precisely how this pain persists has been a mystery, and current treatments are largely ineffective. But a team led by scientists from The Scripps Research Institute, using a new approach known as metabolomics, has now discovered a major clue: dimethylsphingosine (DMS), a small-molecule byproduct of cellular membranes in the nervous system.
In a major step forward in addressing the needs of homeless people in Vancouver who are living with mental illness, the Mental Health Commission of Canada (MHCC) and the PHS Community Services Society today officially opened the Bosman Hotel Community, providing stable housing and support to 100 residents.
› Verified 5 days ago
| Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952461816 PECOS PAC ID: 3779495858 Enrollment ID: O20040105000308 |
News Archive
Today, the success of the Young Investigator Grant for Probiotics Research (YIGPRO) program was confirmed with the announcement of two $50,000 grants that are available to rising young investigators in the field of probiotics. 2010 marks the third consecutive year for the grants. The grants were established by The Global Probiotics Council (GPC), a committee formed by DANONE and Yakult Honsha Co., Ltd., and are designed to contribute to the advancement of probiotics and gastrointestinal microbiota research in the United States.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), announced today that it has entered into a research collaboration with Mirna Therapeutics (Austin, TX), to determine the utility of combining RXi's proprietary rxRNA™ technology with Mirna's microRNA mimics as potential therapeutics in oncology. The parties will each contribute technology and resources to the collaboration to generate and evaluate novel microRNA compounds.
Millions of people worldwide suffer from a type of chronic pain called neuropathic pain, which is triggered by nerve damage. Precisely how this pain persists has been a mystery, and current treatments are largely ineffective. But a team led by scientists from The Scripps Research Institute, using a new approach known as metabolomics, has now discovered a major clue: dimethylsphingosine (DMS), a small-molecule byproduct of cellular membranes in the nervous system.
In a major step forward in addressing the needs of homeless people in Vancouver who are living with mental illness, the Mental Health Commission of Canada (MHCC) and the PHS Community Services Society today officially opened the Bosman Hotel Community, providing stable housing and support to 100 residents.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Danielle Saint Ulme Jean, MD 3323 Beaverwood Ln, Silver Spring, MD 20906-3064 Ph: (301) 871-0658 | Dr Danielle Saint Ulme Jean, MD 3301 Wilson Blvd, Arlington, VA 22201 Ph: (703) 243-6720 |
News Archive
Today, the success of the Young Investigator Grant for Probiotics Research (YIGPRO) program was confirmed with the announcement of two $50,000 grants that are available to rising young investigators in the field of probiotics. 2010 marks the third consecutive year for the grants. The grants were established by The Global Probiotics Council (GPC), a committee formed by DANONE and Yakult Honsha Co., Ltd., and are designed to contribute to the advancement of probiotics and gastrointestinal microbiota research in the United States.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), announced today that it has entered into a research collaboration with Mirna Therapeutics (Austin, TX), to determine the utility of combining RXi's proprietary rxRNA™ technology with Mirna's microRNA mimics as potential therapeutics in oncology. The parties will each contribute technology and resources to the collaboration to generate and evaluate novel microRNA compounds.
Millions of people worldwide suffer from a type of chronic pain called neuropathic pain, which is triggered by nerve damage. Precisely how this pain persists has been a mystery, and current treatments are largely ineffective. But a team led by scientists from The Scripps Research Institute, using a new approach known as metabolomics, has now discovered a major clue: dimethylsphingosine (DMS), a small-molecule byproduct of cellular membranes in the nervous system.
In a major step forward in addressing the needs of homeless people in Vancouver who are living with mental illness, the Mental Health Commission of Canada (MHCC) and the PHS Community Services Society today officially opened the Bosman Hotel Community, providing stable housing and support to 100 residents.
› Verified 5 days ago
Roza H Hassen, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1005 N Glebe Rd Ste 160, Arlington, VA 22201 Phone: 571-492-3045 Fax: 571-492-3046 | |
Dr. Mary Cathleen Nishimura, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 888 N Quincy St Unit 2105, Arlington, VA 22203 Phone: 717-609-5897 | |
Zain Jalal Sultan, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3600 S Glebe Rd Ste 110, Arlington, VA 22202 Phone: 571-665-6480 Fax: 571-665-6481 | |
Dr. Carl W Mccord, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 950 N Glebe Rd Ste 700, Arlington, VA 22203 Phone: 571-933-4662 Fax: 866-343-0947 | |
Lee Baldwin Martin Jr., MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 437 N Park Dr, Ste 1, Arlington, VA 22203 Phone: 703-527-1339 Fax: 703-527-9733 | |
Dr. Janet F Regier, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4201 Wilson Blvd, Health Unit Room 265 S, Arlington, VA 22230 Phone: 703-292-4401 Fax: 703-292-9001 | |
Dr. Jennifer T Neria, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1625 N George Mason Dr, Suite 434, Arlington, VA 22205 Phone: 703-522-1860 Fax: 703-522-7293 |